期刊文献+

胸苷磷酸化酶、中期因子及CD105在喉癌组织中的表达及临床意义

The expressions of TP,MK and CD105 in laryngeal squamous cell carcinoma and their clinical significance
原文传递
导出
摘要 目的:探讨胸苷磷酸化酶(TP)、中期因子(MK)和CD105在喉鳞状细胞癌组织中的表达及临床意义。方法:采用免疫组织化学方法检测43例喉鳞状细胞癌组织中TP、MK的表达和CD105标记的微血管密度(MVD)情况。结果:TP的阳性表达率为67.4%,MK的阳性表达率为60.5%,CD105标记的MVD值为6.01±1.78。TP和MK均为阳性时CD105标记的MVD值(7.07±3.26)明显高于TP和MK均为阴性时的MVD值(4.03±1.90)(P<0.05)。三者表达均与临床分期、淋巴结转移有关。单因素分析显示TP、MK表达和高MVD(≥6)均影响喉癌患者的生存期,但通过多因素分析显示只有淋巴结转移和MVD是影响喉癌患者生存期的预后因素。结论:TP、MK表达与喉癌血管生成关系密切,是喉癌肿瘤血管生成的重要因子,三者与喉癌进展、淋巴结转移密切相关。淋巴结转移和CD105标记的MVD是影响喉癌预后的因素;TP、MK可能通过促肿瘤血管生成作用对喉癌预后产生影响;TP、MK及CD105可作为一组有价值的肿瘤标记和预后指标。 Objective:To explore the expressions of thymidine phosphorylase(TP),midkine(MK) and MVD marked with CD105 antibody in laryngeal squamous cell carcinoma(LSCC) and their clinical significance.Method:The expressions of TP,MK and CD105 in LSCC tissues of 43 cases were studied by immunohistochemical staining.Result:The positive expression rates of TP and MK in LSCC were 67.4% and 60.5% respectively,the mean vaule of MVD was 6.01±1.78.MVD was significantly higher in tumor tissue with both positive TP and MK than in that with both negative TP and MK(7.07±3.26 vs 4.03±1.90,P〈0.05).The expression of TP,MK and CD105 were all correlated with T-stage and lymph node metastasis.Positive TP,MK expression and high MVD were all associated with a poor survival,and positive expression of both TP and MK in tumors conferred a poorer prognosis than negative expression of those factors in tumors,but only the lymph node metastasis and MVD were independent prognostic factors on multivariate analysis.Conclusion:Both TP and MK are important for angiogenesis in LSCC.TP,MK and angiogenesis are all closely correlated with the progress of LSCC and the lymph node metastasis.The lymph node metastasis and MVD marked with CD105 antibody were independent prognostic factors.TP and MK may affect the progression and prognosis of tumor by promotion of angiogenesis.A combinative detection of TP,MK and CD105 can be as valuable tumor marker and prognostic factor for LSCC.
出处 《临床耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2008年第3期100-103,共4页 Journal of Clinical Otorhinolaryngology Head And Neck Surgery
基金 十一五全军医药卫生科研基金课题面上项目(No:06MA142)
关键词 喉肿瘤 鳞状细胞 胸苷磷酸化酶 中期因子 抗原 CD105 Laryngeal neoplasms Carcinoma,squamous cell Thymidine phosphorylase Midkine Antigens,CD105
  • 相关文献

参考文献15

  • 1TO I M, ATIQUR RAHMAN M, BANDO H, et al. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment [J]. Lancet Oncol, 2005,6 : 158-166.
  • 2IKEMATSU S, YANO A, ARIDOME K, et al. Serum midkine levels are increased in patients with various types of carcinomas[J]. Br J Cancer, 2000,83:701-706.
  • 3KADOMATSU K. Recent progress of midkine research on cancer[J]. Nippon Rinsho, 2000,58: 1337-1347.
  • 4KONISHI N, NAKAMURA M, NAKAOKA S, et al. Immunohistochemical analysis of midkine expres- sion in human prostate carcinoma [J]. Oncology,1999,57:253-257.
  • 5YE C, QI M, FAN Q W, et al. Expression of midkine in the early stage of carcinogenesis in human colorectal cancer[J]. Br J Cancer, 1999,79 : 179-184.
  • 6KEN-ICHI S, HIDEYUKI K, MITSUKO N, et al. Nestin as a marker for proliferative endothelium in gliomas[J]. Lab Invest, 2002,82 : 345-351.
  • 7STEVENSON D P, MILLIGAN S R, COLLINS W P. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and prod- ucts in a three-dimensional model of angiogenesis[J]. Am J Pathol,1998,152:1641-1646.
  • 8IKEDA R, FURUKAWA T, KITAZONO M, et al. Molecular basis for the inhibition of hypoxia-induced apoptosis by 2-deoxy-Dribose [J]. Biochem Biophys Res Commun,2002,291:806-812.
  • 9ISHIKAWA T, UTOH M, SAWADA N, et al. Tumor selective delivery of 5-Fura by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts[J]. Biochem Pharmacol, 1998,55 : 1091 - 1097.
  • 10HITT R, JIMENO A, RODRIGUEZ-PINILLA M, et al. Phase Ⅱ trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors[J]. Br J Cancer,2004,91:2005-2011.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部